251 related articles for article (PubMed ID: 7242313)
21. [A new antianginal preparation: isosorbide-5-mononitrate].
Martsevich SIu; Metelitsa VI; Slastnikova ID; Simkhaev LS; Egorov LV; Blagodatskikh SV
Kardiologiia; 1990 Oct; 30(10):44-6. PubMed ID: 2290270
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
23. [Time-dependent hemodynamic effects of monosan (Isosorbide-5-mononitrate) in anginal patients].
Zholdin BK; Zaslavskaia RM; Zhamankulov KA
Klin Med (Mosk); 1998; 76(4):30-2. PubMed ID: 9613078
[TBL] [Abstract][Full Text] [Related]
24. Isosorbide mononitrate for angina.
Med Lett Drugs Ther; 1992 Jun; 34(873):61. PubMed ID: 1608345
[No Abstract] [Full Text] [Related]
25. Mononitrates as monotherapy in the prophylactic treatment of angina pectoris.
Rehnqvist N; Nyberg G; Carlens P; Lindström E; Lundman T; Nordlander R; Ulvenstam G; Aberg A; Aström H
Drugs; 1987; 33 Suppl 4():100-3. PubMed ID: 3622313
[TBL] [Abstract][Full Text] [Related]
26. [Influence of isosorbide-5-mononitrate on the tolerance test to exertion in angina pectoris].
Cherchi A; Lai C; Onnis E; Cherchi A; Meloni L; Pirisi R
Cardiologia; 1985 Jun; 30(6):439-48. PubMed ID: 3833355
[No Abstract] [Full Text] [Related]
27. Long-acting isosorbide mononitrate.
Prakash A; Markham A
Drugs; 1999 Jan; 57(1):93-9; discussion 100. PubMed ID: 9951954
[TBL] [Abstract][Full Text] [Related]
28. Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary heart disease: a multi-centre study.
Bidoggia H
Curr Med Res Opin; 1987; 10(9):601-11. PubMed ID: 3325229
[TBL] [Abstract][Full Text] [Related]
29. The therapeutic role of isosorbide-5-mononitrate+ in stable and unstable angina pectoris.
Distante A; Lombardi M; Moscarelli E; Morales MA; L'Abbate A
Z Kardiol; 1986; 75 Suppl 3():38-41. PubMed ID: 3541417
[TBL] [Abstract][Full Text] [Related]
30. Experience of long term treatment and different dosage regimens of isosorbide 5-mononitrate.
Meffert M; Paeckelmann IM
Drugs; 1987; 33 Suppl 4():104-10. PubMed ID: 3622314
[TBL] [Abstract][Full Text] [Related]
31. Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris.
Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Reinikainen P
Eur Heart J; 1988 Dec; 9(12):1339-47. PubMed ID: 3147892
[TBL] [Abstract][Full Text] [Related]
32. [Changes in exercise capacity and in induced ischemia with an oral dose of 5 isosorbide mononitrate in patients with stable angina pectoris].
Martín Luengo C; Nieto Ballesteros F; Santos Rodríguez I; Diego Domínguez M; Fernández Esteban T; Avila Escribano C; Pavón Osuna P; Cascón Bueno M
An Med Interna; 1990 Jan; 7(1):24-7. PubMed ID: 2103193
[TBL] [Abstract][Full Text] [Related]
33. Influence of isosorbide-5-mononitrate on the circadian rhythm of angina pectoris.
Ganzinger U
Arzneimittelforschung; 1992 Mar; 42(3):307-10. PubMed ID: 1497689
[TBL] [Abstract][Full Text] [Related]
34. Slow release isosorbide-5-mononitrate therapy in angina pectoris. Effects of exercise performance and hemodynamics.
Jansen W; Prenzel R; Rappert B; Kümper H; Laufen H; Tauchert M
Cardiology; 1991; 79 Suppl 2():78-85. PubMed ID: 1760835
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the therapeutic efficacy of slow-release isosorbide-5-mononitrate in ischemic cardiopathy].
Schiavoni G; Bosimini E; Amico C
Cardiologia; 1987 Nov; 32(11):1293-6. PubMed ID: 3447702
[No Abstract] [Full Text] [Related]
36. Comparison of antianginal efficacy of sustained release isosorbide dinitrate with short-acting isosorbide dinitrate.
Joseph G
Indian Heart J; 1991; 43(6):477. PubMed ID: 1823901
[No Abstract] [Full Text] [Related]
37. [Anti-angina action and tolerance of isosorbide-5-mononitrate or nifedipine in retard form].
Erlemeier HH; Kupper W; Lange S; Bleifeld W
Z Kardiol; 1986; 75 Suppl 3():112-4. PubMed ID: 3541415
[TBL] [Abstract][Full Text] [Related]
38. The rationale for nitrates in angina pectoris.
Held P; Olsson G
Can J Cardiol; 1995 Apr; 11 Suppl B():11B-13B. PubMed ID: 7728648
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of the efficacy and duration of action of 2 isosorbide dinitrate preparations].
Magelli C; Marzocchi A; Ferretti RM; Bassein L; Magnani B
Cardiologia; 1982; 27(6):609-14. PubMed ID: 6892440
[No Abstract] [Full Text] [Related]
40. Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris.
Wisenberg G; Roks C; Nichol P; Goddard MD
Am J Cardiol; 1989 Sep; 64(10):569-76. PubMed ID: 2782247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
